Česká technologická platforma pro potraviny


INFORMACE

O značku Regionální potravina přišel Kefír výrobce Jana Svatošová
25.10.2019

Setkání k projektu GoNano
22.10.2019

Tolerance rostlin vůči železu
18.10.2019

SVS podá trestní oznámení pro podezření na týrání zvířat na jatkách
18.10.2019

Ctpp >


Konference "2017 Diabetes Summit", 5. - 7. 4. 2017
Datum: 18.01.2017
Global Technology Community

https://www.gtcbio.com/conferences/diabetes-summit-overview?utm_source=newsletter2&utm_medium=diabetes17&utm_campaign=diabetes17I

Dear Colleague,

GTCbio and the advisory board would like to invite you to the 2017 Diabetes Summit to be held April 5-7, 2017 in Boston, MA. This unique event encompasses the drug discovery and partnering aspects of diabetes in two individual conferences that take place concurrently:

Conference 1: 10th Diabetes Drug Discovery & Development Conference

  1. Going Back to the Basics - Street Light Effect
  2. Novel Therapeutic Targets & Strategies
  3. Translation to The Clinic: What's in the Pipeline


Joint: Plenary Session :

  1. Where do We Stand with Stem Cell Therapy in Diabetes?


Conference 2: 7th Diabetes Partnering & Deal-Making Conference

  1. Current Trends and Future Projections for Investments
  2. Partnering and Licensing Opportunities
  3. Devices and Digital Aids in Diabetes Management
  4. Investment in Disease Modifying Therapies
  5. Patient Entrepreneur Panel
  6. Biotech Showcase: Emerging Pipelines


Experts from industry and academia will discuss the bionic pancreas, bariatric surgery, the gut microbiome, obesity, and emerging therapies to target Type 1 and Type 2 diabetes in sessions and panels geared towards novel therapeutic strategies, drug discovery, and partnering with pharmaceuticals, biotech firms, and academic institutions.

We look forward to seeing you at the conference!


Best regards,

The 2017 Advisory Committee

2017 Advisory Board Members
Robert Geho, Diasome Pharmaceuticals Inc
Zan Fleming, Kinexum
Alan Cherrington, Vanderbilt
Nirja Patel, ALPCO Diagnostics
Vivek Shenoy, Renovo